Measurement, Design, and Analysis Methods for Health Outcomes Research

  • Online
  • September 2327, 2024
  • $2,500

This program is ideal for anyone interested in getting an intensive view of the fundamentals of health outcomes research.
  • —Michael Loechel
  • President & Co-Founder, Axioma Group

Program Overview

Health care systems around the world face growing pressures to provide more effective programs, treatments, and interventions. Health outcomes research is the scientific inquiry that provides the evidence required for optimally developing new therapies, implementing quality of care improvement protocols, and enhancing public health system capacity and capability.

In this online program, Harvard’s expert faculty in health outcomes research will guide you through the language and concepts needed to synthesize outcomes studies into useful knowledge for translation and implementation into practice. During this program you will learn the fundamentals for measuring, designing, and analyzing health outcomes research studies and data.

Why Health Outcomes Research is Important

Outcomes research is highly valued in public health due to the breadth of issues it addresses. A diverse and growing number of organizations – employers, health care delivery organizations, insurers, pharmaceutical companies, and governments – rely on health outcomes research for generating actionable data that will help them make better decisions about the value of different therapeutic and preventative options. Well-designed and executed health outcomes research studies can provide evidence for a broad range of medical and public health practices, such as:

  • Incorporating patient-centered outcomes measures such as patient preference and quality of life into the drug and device development process
  • Evaluating the impact of chronic disease therapies on physical, emotional and social functioning
  • Determining the cost-effectiveness of comparative medical treatments for chronic diseases
  • Assessing the population health risks and benefits associated with response and mitigation strategies for infectious diseases such as influenza and COVID-19

Objectives & Highlights

Learning Objectives

As a participant, you will learn to:

  • Conceptually define the meaning and purpose of outcomes research and evaluation
  • Understand the role of epidemiology, health economics, psychometrics and biostatistics in conducting outcomes research
  • Evaluate the usefulness of outcomes measures and the application of new technologies in medical institutions and industries, health care organizations and public health systems
  • Recognize the different types of measures used in outcomes research, including clinical, health status, quality of life, work/role performance, health care utilization, and patient satisfaction
  • Adopt new methods for modeling responses obtained from individuals completing questionnaires and surveys
  • Interpret and understand scale performance and measurement concepts such as reliability, validity, responsiveness, and sensitivity
  • Understand statistical methods appropriate for analyzing health outcomes data, such as longitudinal methods
  • Synthesize and interpret findings from different types of health outcomes research studies

Credits and Logistics

Continuing Education Credit

The Harvard T.H. Chan School of Public Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard T.H. Chan School of Public Health designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Harvard T.H. Chan School of Public Health will grant 1.6 Continuing Education Units (CEUs) for this program, equivalent to 16.25 contact hours of education. Participants can apply these contact hours toward other professional education accrediting organizations.

All credits subject to final agenda.

All participants will receive a Certificate of Participation upon completion of the program.


Current faculty, subject to change.

Donald C. Simonson, MPH, ScD, MD, MBA

Program Director

September 2327, 2024
Lecturer on Medicine
Department of Medicine
Harvard Medical School

Lecturer on Medicine
Brigham and Women's Hospital/EH&E

Marcia A. Testa, PhD, MPhil, MPH

Program Director

September 2327, 2024
Senior Lecturer on Biostatistics
Department of Biostatistics
Harvard T.H. Chan School of Public Health

Jakob B. Bjørner, MD, PhD


September 2327, 2024
Chief Science Officer
Quality Metric, Inc.

Adjunct Professor
Faculty of Health and Medical Sciences
University of Copenhagen

Honorary Professor
University Of Sheffield

Garrett Fitzmaurice, ScD


September 2327, 2024
McLean Hospital

Professor of Psychiatry (Biostatistics)
Department of Biostatistics
Harvard Medical School

Matthias Rose, MD, PhD


September 2327, 2024
Professor and Chair
Department of Psychosomatic Medicine
Charité - Universitätsmedizin Berlin

Sebastian Schneeweiss, MD, ScD


September 2327, 2024
Professor of Medicine and Epidemiology
Harvard Medical School

Department of Medicine
Brigham and Women's Hospital/EH&E

Alexander Turchin, MS, MD


September 2327, 2024
Director of Informatics Research
Brigham and Women's Hospital/EH&E

John E. Ware Jr., PhD


September 2327, 2024
Visiting Professor
College of Health Sciences
Arizona State University

Adjunct Research Professor
Tufts University School of Medicine

Chief Science Officer and Chairman
John Ware Research Group, Inc.


September 23 – 27, 2024

All Times are Eastern Time (ET).

Monday, September 23, 2024
8:15–9:00 am Program Welcome/Technology Orientation
9:00–10:30 am Testa Outcomes Research: Definitions, Concepts, Measures, and Models
10:30–10:45 am Break
10:45 am–12:00 pm Ware State of the Art Techniques for Health Outcomes Measurement and Evaluation I
12:00–12:30 pm Questions, Discussion, and Networking
Tuesday, September 24, 2024
9:00–10:30 am Testa Clinical Status, Functional Health Quality of Life Questionnaires
10:30–10:45 am Break
10:45 am–12:00 pm Bjørner State of the Art Techniques for Health Outcomes Measurement and Evaluation II
12:00–12:30 pm Questions, Discussion, and Networking
Wednesday, September 25, 2024
9:00–10:30 am Fitzmaurice Longitudinal Data Analysis
10:30–10:45 am Break
10:45 am–12:00 pm Simonson Epidemiology Study Designs for Outcomes Research
12:00–12:30 pm Questions, Discussion, and Networking
Thursday, September 26, 2024
9:00–10:30 am Schneeweiss Effectiveness Research using Healthcare Database Analytics
10:30–10:45 am Break
10:45 am–12:00 pm Turchin Using EMR Data in Clinical Research: Experience and Practical
12:00–12:30 pm Questions, Discussion, and Networking
1:00–2:00 pm Technology Orientation / Meet & Greet (optional)
Friday, September 27, 2024
9:00–10:30 am Simonson Health Economic Outcomes and Analysis
10:30–10:45 am Break
10:45 am–12:00 pm Rose International Application of PRO - Methodological Research to Clinical Practice
12:00–12:30 pm Questions, Discussion, and Networking

This agenda is subject to change.

back to top

Who Should Participate

This program will be useful to anyone involved in improving health care cost, quality, or outcomes from across the health care industry. Ideal participants include:

  • Clinicians, including physicians, nurses, and allied health professionals involved in utilizing outcomes data or assessing, measuring, and evaluating outcomes
  • Health care executives and administrators who review and utilize outcomes data for clinical decision-making and improving quality of care
  • Insurance, managed care, and other payer executives and researchers seeking to understand the relative value of procedures and interventions
  • Pharmaceutical and biotechnology executives and researchers who need to measure patient-reported outcomes to support the benefit of their products
  • Other health sector researchers who are new to outcomes research and need an overview of the latest information in the field

Registration Criteria

Participants must have an advanced degree (e.g., MD, PhD, MS, MPH, PharmD) in a relevant discipline. Proficiency in written and spoken English is essential for a successful learning experience in the program.